Supriya Lifescience Limited Share Price & Stock Analysis

Supriya Lifescience Limited (NSE: SUPRIYA, BSE: 543434) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹5,134 Cr, it ranks #827 by market cap among the 6,197 Indian listed companies on FinBizNet, and #25 of 86 in Medicinal Chemicals and Botanical Products. At ₹632.30 (as of 16 Nov 2026), the share price is 41.7% below its 52-week high of ₹1,085.00 and 15.9% above its 52-week low of ₹545.50. The share price is down 18.9% over one year and down 22.3% over three months.

Key Metrics

Current Price₹632.30
Market Cap₹5,134 Cr
NSE SymbolSUPRIYA
BSE Code543434
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio24.7
Return on Equity19.06%
Return on Assets13.46%
52-Week Range₹545.50 – ₹1,085.00
1-Year Price Change-18.9%
3-Month Price Change-22.3%
Beta (1Y)0.76
Dividend Yield0.16%
HeadquartersMumbai, Maharashtra
Websitewww.supriyalifescience.com

Latest Quarterly Results — Q2 FY27

Revenue₹206 Cr
Net Profit₹29 Cr
Net Margin14.2%
EPS (Basic)₹3.63
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Supriya Lifescience Limited Quarterly Revenue and Profit Trend

Supriya Lifescience Limited reported revenue of ₹206 Cr in Q2 FY27, up 3.2% from ₹200 Cr in Q2 FY26 and up 8.7% from ₹190 Cr in Q1 FY27. It posted a net profit of ₹29 Cr for the quarter, against a net profit of ₹50 Cr in Q2 FY26 (down 42.0%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹145 Cr (Q1 FY26) to ₹277 Cr (Q4 FY26). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹206 Cr₹29 Cr14.2%
Q1 FY27₹190 Cr₹24 Cr12.7%
Q4 FY26₹277 Cr₹74 Cr26.8%
Q3 FY26₹206 Cr₹50 Cr24.1%
Q2 FY26₹200 Cr₹50 Cr25.2%
Q1 FY26₹145 Cr₹35 Cr24.0%
Q4 FY25₹184 Cr₹50 Cr27.4%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 68.30% of Supriya Lifescience Limited's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 41.8% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Supriya Lifescience Limited

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.

Products and Services

1. Specialty Chemicals-This segment engages in the research and development, manufacture, and sale of active pharmaceutical ingredients.

Business Segments

1. Specialty Chemicals-100%

Supriya Lifescience Limited vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Supriya Lifescience Limited₹5,134 Cr24.719.06%₹206 Cr-18.9%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Supriya Lifescience Limited?

Supriya Lifescience Limited is trading at ₹632.30, with a market capitalisation of ₹5,134 Cr.

Which sector does Supriya Lifescience Limited belong to?

Supriya Lifescience Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Supriya Lifescience Limited?

Supriya Lifescience Limited has a P/E of 24.7 and a return on equity of 19.06%.

What is the stock symbol of Supriya Lifescience Limited?

Supriya Lifescience Limited is listed on the NSE under the symbol SUPRIYA and on the BSE under the scrip code 543434.

How has Supriya Lifescience Limited's share price moved over the past year?

Supriya Lifescience Limited's share price is down 18.9% over one year and down 22.3% over three months. Its 52-week range is ₹545.50 to ₹1,085.00.

What were Supriya Lifescience Limited's latest quarterly results?

In Q2 FY27, Supriya Lifescience Limited reported revenue of ₹206 Cr and net profit of ₹29 Cr, with basic EPS of ₹3.63 (standalone, parsed from the company's exchange filing).

How have Supriya Lifescience Limited's revenue and profit changed over the past year?

Supriya Lifescience Limited reported revenue of ₹206 Cr in Q2 FY27, up 3.2% from ₹200 Cr in Q2 FY26 and up 8.7% from ₹190 Cr in Q1 FY27.

What is the promoter holding in Supriya Lifescience Limited?

Promoters held 68.30% of Supriya Lifescience Limited's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.